nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—ANKK1—telencephalon—autistic disorder	0.00501	0.0119	CbGeAlD
Ruxolitinib—PHKG2—hindbrain—autistic disorder	0.00455	0.0108	CbGeAlD
Ruxolitinib—HIPK2—hindbrain—autistic disorder	0.00437	0.0104	CbGeAlD
Ruxolitinib—GRK1—eye—autistic disorder	0.00434	0.0103	CbGeAlD
Ruxolitinib—GRK1—forebrain—autistic disorder	0.00431	0.0102	CbGeAlD
Ruxolitinib—PRKCE—forebrain—autistic disorder	0.00421	0.00999	CbGeAlD
Ruxolitinib—RPS6KA6—brainstem—autistic disorder	0.00419	0.00994	CbGeAlD
Ruxolitinib—GRK1—telencephalon—autistic disorder	0.00396	0.00938	CbGeAlD
Ruxolitinib—DYRK1A—hindbrain—autistic disorder	0.00394	0.00933	CbGeAlD
Ruxolitinib—PRKCE—telencephalon—autistic disorder	0.00387	0.00918	CbGeAlD
Ruxolitinib—CAMK2G—hindbrain—autistic disorder	0.00351	0.00831	CbGeAlD
Ruxolitinib—GRK7—head—autistic disorder	0.00341	0.00808	CbGeAlD
Ruxolitinib—PRKG2—digestive system—autistic disorder	0.00317	0.00751	CbGeAlD
Ruxolitinib—CAMK1—forebrain—autistic disorder	0.00316	0.00749	CbGeAlD
Ruxolitinib—ANKK1—head—autistic disorder	0.00312	0.00739	CbGeAlD
Ruxolitinib—MARK2—forebrain—autistic disorder	0.00307	0.00727	CbGeAlD
Ruxolitinib—ANKK1—nervous system—autistic disorder	0.00296	0.00701	CbGeAlD
Ruxolitinib—CAMK1—telencephalon—autistic disorder	0.00291	0.00689	CbGeAlD
Ruxolitinib—PLK1—digestive system—autistic disorder	0.00284	0.00673	CbGeAlD
Ruxolitinib—PHKG2—brainstem—autistic disorder	0.00261	0.00618	CbGeAlD
Ruxolitinib—JAK1—forebrain—autistic disorder	0.00259	0.00614	CbGeAlD
Ruxolitinib—DCLK1—forebrain—autistic disorder	0.00259	0.00614	CbGeAlD
Ruxolitinib—PRKG2—head—autistic disorder	0.00258	0.00612	CbGeAlD
Ruxolitinib—CAMK1D—eye—autistic disorder	0.00255	0.00605	CbGeAlD
Ruxolitinib—CAMK1D—forebrain—autistic disorder	0.00253	0.006	CbGeAlD
Ruxolitinib—HIPK2—brainstem—autistic disorder	0.00251	0.00594	CbGeAlD
Ruxolitinib—TAOK3—hindbrain—autistic disorder	0.00248	0.00587	CbGeAlD
Ruxolitinib—GRK1—head—autistic disorder	0.00247	0.00584	CbGeAlD
Ruxolitinib—PRKG2—nervous system—autistic disorder	0.00245	0.00581	CbGeAlD
Ruxolitinib—HIPK2—forebrain—autistic disorder	0.00242	0.00574	CbGeAlD
Ruxolitinib—PRKCE—head—autistic disorder	0.00241	0.00572	CbGeAlD
Ruxolitinib—JAK1—telencephalon—autistic disorder	0.00238	0.00565	CbGeAlD
Ruxolitinib—DCLK1—telencephalon—autistic disorder	0.00238	0.00565	CbGeAlD
Ruxolitinib—PRKG2—central nervous system—autistic disorder	0.00236	0.00559	CbGeAlD
Ruxolitinib—GRK1—nervous system—autistic disorder	0.00234	0.00554	CbGeAlD
Ruxolitinib—RPS6KA6—head—autistic disorder	0.00232	0.00549	CbGeAlD
Ruxolitinib—PLK1—head—autistic disorder	0.00232	0.00549	CbGeAlD
Ruxolitinib—MAST1—head—autistic disorder	0.00232	0.00549	CbGeAlD
Ruxolitinib—PRKCE—nervous system—autistic disorder	0.00229	0.00542	CbGeAlD
Ruxolitinib—DAPK2—telencephalon—autistic disorder	0.00227	0.00539	CbGeAlD
Ruxolitinib—DYRK1A—brainstem—autistic disorder	0.00226	0.00535	CbGeAlD
Ruxolitinib—ROCK1—eye—autistic disorder	0.00225	0.00534	CbGeAlD
Ruxolitinib—GRK1—central nervous system—autistic disorder	0.00225	0.00533	CbGeAlD
Ruxolitinib—BMPR2—brainstem—autistic disorder	0.00225	0.00532	CbGeAlD
Ruxolitinib—ROCK1—forebrain—autistic disorder	0.00223	0.00529	CbGeAlD
Ruxolitinib—HIPK2—telencephalon—autistic disorder	0.00223	0.00527	CbGeAlD
Ruxolitinib—PRKCE—central nervous system—autistic disorder	0.0022	0.00522	CbGeAlD
Ruxolitinib—PLK1—nervous system—autistic disorder	0.0022	0.00521	CbGeAlD
Ruxolitinib—RPS6KA6—nervous system—autistic disorder	0.0022	0.00521	CbGeAlD
Ruxolitinib—MAST1—nervous system—autistic disorder	0.0022	0.00521	CbGeAlD
Ruxolitinib—DCLK3—head—autistic disorder	0.0022	0.00521	CbGeAlD
Ruxolitinib—DYRK1A—forebrain—autistic disorder	0.00218	0.00516	CbGeAlD
Ruxolitinib—BMPR2—forebrain—autistic disorder	0.00217	0.00514	CbGeAlD
Ruxolitinib—MARK2—digestive system—autistic disorder	0.00215	0.0051	CbGeAlD
Ruxolitinib—PRKCE—cerebellum—autistic disorder	0.00215	0.0051	CbGeAlD
Ruxolitinib—DAPK3—telencephalon—autistic disorder	0.00214	0.00507	CbGeAlD
Ruxolitinib—PLK1—central nervous system—autistic disorder	0.00212	0.00501	CbGeAlD
Ruxolitinib—RPS6KA6—central nervous system—autistic disorder	0.00212	0.00501	CbGeAlD
Ruxolitinib—MAST1—central nervous system—autistic disorder	0.00212	0.00501	CbGeAlD
Ruxolitinib—DCLK3—nervous system—autistic disorder	0.00208	0.00494	CbGeAlD
Ruxolitinib—RPS6KA6—cerebellum—autistic disorder	0.00207	0.0049	CbGeAlD
Ruxolitinib—MAST1—cerebellum—autistic disorder	0.00207	0.0049	CbGeAlD
Ruxolitinib—ROCK1—telencephalon—autistic disorder	0.00205	0.00486	CbGeAlD
Ruxolitinib—CAMK2G—brainstem—autistic disorder	0.00201	0.00477	CbGeAlD
Ruxolitinib—DCLK3—central nervous system—autistic disorder	0.00201	0.00475	CbGeAlD
Ruxolitinib—DYRK1A—telencephalon—autistic disorder	0.002	0.00474	CbGeAlD
Ruxolitinib—BMPR2—telencephalon—autistic disorder	0.00199	0.00473	CbGeAlD
Ruxolitinib—LRRK2—brainstem—autistic disorder	0.00199	0.00472	CbGeAlD
Ruxolitinib—CAMK2G—eye—autistic disorder	0.00196	0.00464	CbGeAlD
Ruxolitinib—CAMK2G—forebrain—autistic disorder	0.00194	0.0046	CbGeAlD
Ruxolitinib—BMP2K—forebrain—autistic disorder	0.00194	0.0046	CbGeAlD
Ruxolitinib—PLK3—head—autistic disorder	0.00193	0.00458	CbGeAlD
Ruxolitinib—LRRK2—forebrain—autistic disorder	0.00192	0.00456	CbGeAlD
Ruxolitinib—PRKG2—brain—autistic disorder	0.00187	0.00444	CbGeAlD
Ruxolitinib—LTK—head—autistic disorder	0.00187	0.00443	CbGeAlD
Ruxolitinib—PLK3—nervous system—autistic disorder	0.00183	0.00435	CbGeAlD
Ruxolitinib—JAK3—digestive system—autistic disorder	0.00183	0.00434	CbGeAlD
Ruxolitinib—JAK1—digestive system—autistic disorder	0.00182	0.00431	CbGeAlD
Ruxolitinib—DCLK1—digestive system—autistic disorder	0.00182	0.00431	CbGeAlD
Ruxolitinib—CAMK1—head—autistic disorder	0.00181	0.00429	CbGeAlD
Ruxolitinib—GRK1—brain—autistic disorder	0.00179	0.00423	CbGeAlD
Ruxolitinib—CAMK2G—telencephalon—autistic disorder	0.00178	0.00423	CbGeAlD
Ruxolitinib—LRRK2—telencephalon—autistic disorder	0.00177	0.00419	CbGeAlD
Ruxolitinib—PLK3—central nervous system—autistic disorder	0.00177	0.00418	CbGeAlD
Ruxolitinib—MARK2—head—autistic disorder	0.00176	0.00416	CbGeAlD
Ruxolitinib—PRKCE—brain—autistic disorder	0.00175	0.00414	CbGeAlD
Ruxolitinib—TYK2—eye—autistic disorder	0.00173	0.0041	CbGeAlD
Ruxolitinib—CAMK1—nervous system—autistic disorder	0.00172	0.00407	CbGeAlD
Ruxolitinib—STK16—digestive system—autistic disorder	0.00171	0.00405	CbGeAlD
Ruxolitinib—MKNK2—eye—autistic disorder	0.00171	0.00404	CbGeAlD
Ruxolitinib—HIPK2—digestive system—autistic disorder	0.0017	0.00403	CbGeAlD
Ruxolitinib—PLK1—brain—autistic disorder	0.00168	0.00398	CbGeAlD
Ruxolitinib—RPS6KA6—brain—autistic disorder	0.00168	0.00398	CbGeAlD
Ruxolitinib—MAST1—brain—autistic disorder	0.00168	0.00398	CbGeAlD
Ruxolitinib—MARK2—nervous system—autistic disorder	0.00167	0.00395	CbGeAlD
Ruxolitinib—CAMK1—central nervous system—autistic disorder	0.00165	0.00391	CbGeAlD
Ruxolitinib—MAP3K2—telencephalon—autistic disorder	0.00162	0.00384	CbGeAlD
Ruxolitinib—CAMK1—cerebellum—autistic disorder	0.00161	0.00383	CbGeAlD
Ruxolitinib—MAP3K7—telencephalon—autistic disorder	0.0016	0.0038	CbGeAlD
Ruxolitinib—MARK2—central nervous system—autistic disorder	0.0016	0.0038	CbGeAlD
Ruxolitinib—DCLK3—brain—autistic disorder	0.00159	0.00377	CbGeAlD
Ruxolitinib—TYK2—telencephalon—autistic disorder	0.00158	0.00374	CbGeAlD
Ruxolitinib—MARK2—cerebellum—autistic disorder	0.00157	0.00371	CbGeAlD
Ruxolitinib—ROCK1—digestive system—autistic disorder	0.00157	0.00371	CbGeAlD
Ruxolitinib—JAK2—forebrain—autistic disorder	0.00156	0.0037	CbGeAlD
Ruxolitinib—IRAK1—telencephalon—autistic disorder	0.00156	0.00369	CbGeAlD
Ruxolitinib—MKNK2—telencephalon—autistic disorder	0.00156	0.00369	CbGeAlD
Ruxolitinib—BMPR2—digestive system—autistic disorder	0.00152	0.00361	CbGeAlD
Ruxolitinib—JAK3—head—autistic disorder	0.00149	0.00354	CbGeAlD
Ruxolitinib—JAK1—head—autistic disorder	0.00148	0.00352	CbGeAlD
Ruxolitinib—DCLK1—head—autistic disorder	0.00148	0.00352	CbGeAlD
Ruxolitinib—TAOK2—cerebellum—autistic disorder	0.00145	0.00344	CbGeAlD
Ruxolitinib—CAMK1D—head—autistic disorder	0.00145	0.00343	CbGeAlD
Ruxolitinib—PHKG2—head—autistic disorder	0.00144	0.00341	CbGeAlD
Ruxolitinib—JAK2—telencephalon—autistic disorder	0.00143	0.0034	CbGeAlD
Ruxolitinib—TAOK3—brainstem—autistic disorder	0.00142	0.00336	CbGeAlD
Ruxolitinib—JAK3—nervous system—autistic disorder	0.00142	0.00336	CbGeAlD
Ruxolitinib—JAK1—nervous system—autistic disorder	0.00141	0.00334	CbGeAlD
Ruxolitinib—DCLK1—nervous system—autistic disorder	0.00141	0.00334	CbGeAlD
Ruxolitinib—PLK3—brain—autistic disorder	0.0014	0.00332	CbGeAlD
Ruxolitinib—STK16—head—autistic disorder	0.00139	0.0033	CbGeAlD
Ruxolitinib—HIPK2—head—autistic disorder	0.00139	0.00328	CbGeAlD
Ruxolitinib—TAOK3—eye—autistic disorder	0.00138	0.00328	CbGeAlD
Ruxolitinib—CAMK1D—nervous system—autistic disorder	0.00137	0.00326	CbGeAlD
Ruxolitinib—TAOK3—forebrain—autistic disorder	0.00137	0.00325	CbGeAlD
Ruxolitinib—PHKG2—nervous system—autistic disorder	0.00137	0.00324	CbGeAlD
Ruxolitinib—JAK3—central nervous system—autistic disorder	0.00136	0.00323	CbGeAlD
Ruxolitinib—CAMK2G—digestive system—autistic disorder	0.00136	0.00323	CbGeAlD
Ruxolitinib—MAP3K19—head—autistic disorder	0.00136	0.00322	CbGeAlD
Ruxolitinib—JAK1—central nervous system—autistic disorder	0.00135	0.00321	CbGeAlD
Ruxolitinib—DCLK1—central nervous system—autistic disorder	0.00135	0.00321	CbGeAlD
Ruxolitinib—LTK—brain—autistic disorder	0.00135	0.00321	CbGeAlD
Ruxolitinib—JAK3—cerebellum—autistic disorder	0.00133	0.00316	CbGeAlD
Ruxolitinib—DAPK3—head—autistic disorder	0.00133	0.00316	CbGeAlD
Ruxolitinib—JAK1—cerebellum—autistic disorder	0.00132	0.00314	CbGeAlD
Ruxolitinib—DCLK1—cerebellum—autistic disorder	0.00132	0.00314	CbGeAlD
Ruxolitinib—CAMK1D—central nervous system—autistic disorder	0.00132	0.00313	CbGeAlD
Ruxolitinib—STK16—nervous system—autistic disorder	0.00132	0.00313	CbGeAlD
Ruxolitinib—CLK2—head—autistic disorder	0.00132	0.00313	CbGeAlD
Ruxolitinib—PHKG2—central nervous system—autistic disorder	0.00131	0.00312	CbGeAlD
Ruxolitinib—HIPK2—nervous system—autistic disorder	0.00131	0.00311	CbGeAlD
Ruxolitinib—CAMK1—brain—autistic disorder	0.00131	0.00311	CbGeAlD
Ruxolitinib—CAMK1D—cerebellum—autistic disorder	0.00129	0.00306	CbGeAlD
Ruxolitinib—MAP3K19—nervous system—autistic disorder	0.00129	0.00305	CbGeAlD
Ruxolitinib—PHKG2—cerebellum—autistic disorder	0.00128	0.00305	CbGeAlD
Ruxolitinib—ROCK1—head—autistic disorder	0.00128	0.00303	CbGeAlD
Ruxolitinib—MARK2—brain—autistic disorder	0.00127	0.00302	CbGeAlD
Ruxolitinib—STK16—central nervous system—autistic disorder	0.00127	0.00301	CbGeAlD
Ruxolitinib—HIPK2—central nervous system—autistic disorder	0.00126	0.003	CbGeAlD
Ruxolitinib—DAPK2—cerebellum—autistic disorder	0.00126	0.00299	CbGeAlD
Ruxolitinib—DAPK3—nervous system—autistic disorder	0.00126	0.00299	CbGeAlD
Ruxolitinib—TAOK3—telencephalon—autistic disorder	0.00126	0.00299	CbGeAlD
Ruxolitinib—CLK2—nervous system—autistic disorder	0.00125	0.00296	CbGeAlD
Ruxolitinib—DYRK1A—head—autistic disorder	0.00125	0.00295	CbGeAlD
Ruxolitinib—STK16—cerebellum—autistic disorder	0.00124	0.00295	CbGeAlD
Ruxolitinib—BMPR2—head—autistic disorder	0.00124	0.00294	CbGeAlD
Ruxolitinib—MAP3K19—central nervous system—autistic disorder	0.00124	0.00294	CbGeAlD
Ruxolitinib—HIPK2—cerebellum—autistic disorder	0.00124	0.00293	CbGeAlD
Ruxolitinib—DAPK3—central nervous system—autistic disorder	0.00122	0.00288	CbGeAlD
Ruxolitinib—ROCK1—nervous system—autistic disorder	0.00121	0.00287	CbGeAlD
Ruxolitinib—CLK2—central nervous system—autistic disorder	0.0012	0.00285	CbGeAlD
Ruxolitinib—TYK2—digestive system—autistic disorder	0.0012	0.00285	CbGeAlD
Ruxolitinib—DAPK3—cerebellum—autistic disorder	0.00119	0.00281	CbGeAlD
Ruxolitinib—MKNK2—digestive system—autistic disorder	0.00119	0.00281	CbGeAlD
Ruxolitinib—DYRK1A—nervous system—autistic disorder	0.00118	0.0028	CbGeAlD
Ruxolitinib—TAOK2—brain—autistic disorder	0.00118	0.00279	CbGeAlD
Ruxolitinib—BMPR2—nervous system—autistic disorder	0.00118	0.00279	CbGeAlD
Ruxolitinib—CLK2—cerebellum—autistic disorder	0.00118	0.00279	CbGeAlD
Ruxolitinib—ROCK1—central nervous system—autistic disorder	0.00117	0.00277	CbGeAlD
Ruxolitinib—RET—digestive system—autistic disorder	0.00116	0.00274	CbGeAlD
Ruxolitinib—DYRK1A—central nervous system—autistic disorder	0.00114	0.0027	CbGeAlD
Ruxolitinib—BMPR2—central nervous system—autistic disorder	0.00113	0.00269	CbGeAlD
Ruxolitinib—DYRK1A—cerebellum—autistic disorder	0.00111	0.00264	CbGeAlD
Ruxolitinib—BMP2K—head—autistic disorder	0.00111	0.00263	CbGeAlD
Ruxolitinib—CAMK2G—head—autistic disorder	0.00111	0.00263	CbGeAlD
Ruxolitinib—BMPR2—cerebellum—autistic disorder	0.00111	0.00263	CbGeAlD
Ruxolitinib—LRRK2—head—autistic disorder	0.0011	0.00261	CbGeAlD
Ruxolitinib—JAK2—digestive system—autistic disorder	0.00109	0.00259	CbGeAlD
Ruxolitinib—JAK3—brain—autistic disorder	0.00108	0.00257	CbGeAlD
Ruxolitinib—JAK1—brain—autistic disorder	0.00108	0.00255	CbGeAlD
Ruxolitinib—DCLK1—brain—autistic disorder	0.00108	0.00255	CbGeAlD
Ruxolitinib—PLK4—brain—autistic disorder	0.00107	0.00253	CbGeAlD
Ruxolitinib—NUAK2—cerebellum—autistic disorder	0.00106	0.00251	CbGeAlD
Ruxolitinib—CAMK2G—nervous system—autistic disorder	0.00105	0.0025	CbGeAlD
Ruxolitinib—BMP2K—nervous system—autistic disorder	0.00105	0.0025	CbGeAlD
Ruxolitinib—CAMK1D—brain—autistic disorder	0.00105	0.00249	CbGeAlD
Ruxolitinib—LRRK2—nervous system—autistic disorder	0.00104	0.00247	CbGeAlD
Ruxolitinib—PHKG2—brain—autistic disorder	0.00104	0.00247	CbGeAlD
Ruxolitinib—DAPK2—brain—autistic disorder	0.00103	0.00243	CbGeAlD
Ruxolitinib—BMP2K—central nervous system—autistic disorder	0.00101	0.0024	CbGeAlD
Ruxolitinib—CAMK2G—central nervous system—autistic disorder	0.00101	0.0024	CbGeAlD
Ruxolitinib—STK16—brain—autistic disorder	0.00101	0.00239	CbGeAlD
Ruxolitinib—MAP3K2—head—autistic disorder	0.00101	0.00239	CbGeAlD
Ruxolitinib—LRRK2—central nervous system—autistic disorder	0.00101	0.00238	CbGeAlD
Ruxolitinib—HIPK2—brain—autistic disorder	0.001	0.00238	CbGeAlD
Ruxolitinib—CAMK2G—cerebellum—autistic disorder	0.000991	0.00235	CbGeAlD
Ruxolitinib—BMP2K—cerebellum—autistic disorder	0.000991	0.00235	CbGeAlD
Ruxolitinib—MAP3K19—brain—autistic disorder	0.000984	0.00233	CbGeAlD
Ruxolitinib—LRRK2—cerebellum—autistic disorder	0.000982	0.00233	CbGeAlD
Ruxolitinib—TYK2—head—autistic disorder	0.000981	0.00233	CbGeAlD
Ruxolitinib—MKNK2—head—autistic disorder	0.000969	0.0023	CbGeAlD
Ruxolitinib—DAPK3—brain—autistic disorder	0.000965	0.00229	CbGeAlD
Ruxolitinib—TAOK3—digestive system—autistic disorder	0.000962	0.00228	CbGeAlD
Ruxolitinib—MAP3K2—nervous system—autistic disorder	0.000956	0.00227	CbGeAlD
Ruxolitinib—CLK2—brain—autistic disorder	0.000956	0.00226	CbGeAlD
Ruxolitinib—RET—head—autistic disorder	0.000945	0.00224	CbGeAlD
Ruxolitinib—TYK2—nervous system—autistic disorder	0.00093	0.00221	CbGeAlD
Ruxolitinib—ROCK1—brain—autistic disorder	0.000926	0.0022	CbGeAlD
Ruxolitinib—MAP3K2—central nervous system—autistic disorder	0.000921	0.00218	CbGeAlD
Ruxolitinib—MKNK2—nervous system—autistic disorder	0.000918	0.00218	CbGeAlD
Ruxolitinib—DYRK1A—brain—autistic disorder	0.000903	0.00214	CbGeAlD
Ruxolitinib—MAP3K2—cerebellum—autistic disorder	0.0009	0.00213	CbGeAlD
Ruxolitinib—BMPR2—brain—autistic disorder	0.0009	0.00213	CbGeAlD
Ruxolitinib—TYK2—central nervous system—autistic disorder	0.000896	0.00212	CbGeAlD
Ruxolitinib—RET—nervous system—autistic disorder	0.000896	0.00212	CbGeAlD
Ruxolitinib—JAK2—head—autistic disorder	0.000893	0.00212	CbGeAlD
Ruxolitinib—MAP3K7—cerebellum—autistic disorder	0.000892	0.00211	CbGeAlD
Ruxolitinib—MKNK2—central nervous system—autistic disorder	0.000884	0.0021	CbGeAlD
Ruxolitinib—TYK2—cerebellum—autistic disorder	0.000876	0.00208	CbGeAlD
Ruxolitinib—IRAK1—cerebellum—autistic disorder	0.000864	0.00205	CbGeAlD
Ruxolitinib—MKNK2—cerebellum—autistic disorder	0.000864	0.00205	CbGeAlD
Ruxolitinib—RET—central nervous system—autistic disorder	0.000862	0.00204	CbGeAlD
Ruxolitinib—MAP3K3—head—autistic disorder	0.000861	0.00204	CbGeAlD
Ruxolitinib—NUAK2—brain—autistic disorder	0.00086	0.00204	CbGeAlD
Ruxolitinib—JAK2—nervous system—autistic disorder	0.000846	0.00201	CbGeAlD
Ruxolitinib—RET—cerebellum—autistic disorder	0.000843	0.002	CbGeAlD
Ruxolitinib—MAP3K3—nervous system—autistic disorder	0.000816	0.00193	CbGeAlD
Ruxolitinib—JAK2—central nervous system—autistic disorder	0.000815	0.00193	CbGeAlD
Ruxolitinib—CAMK2G—brain—autistic disorder	0.000805	0.00191	CbGeAlD
Ruxolitinib—BMP2K—brain—autistic disorder	0.000805	0.00191	CbGeAlD
Ruxolitinib—LRRK2—brain—autistic disorder	0.000798	0.00189	CbGeAlD
Ruxolitinib—JAK2—cerebellum—autistic disorder	0.000797	0.00189	CbGeAlD
Ruxolitinib—MAP3K3—central nervous system—autistic disorder	0.000785	0.00186	CbGeAlD
Ruxolitinib—TAOK3—head—autistic disorder	0.000785	0.00186	CbGeAlD
Ruxolitinib—MAP3K3—cerebellum—autistic disorder	0.000768	0.00182	CbGeAlD
Ruxolitinib—TAOK3—nervous system—autistic disorder	0.000744	0.00176	CbGeAlD
Ruxolitinib—MAP3K2—brain—autistic disorder	0.000731	0.00173	CbGeAlD
Ruxolitinib—MAP3K7—brain—autistic disorder	0.000724	0.00172	CbGeAlD
Ruxolitinib—TAOK3—central nervous system—autistic disorder	0.000716	0.0017	CbGeAlD
Ruxolitinib—TYK2—brain—autistic disorder	0.000711	0.00169	CbGeAlD
Ruxolitinib—IRAK1—brain—autistic disorder	0.000702	0.00166	CbGeAlD
Ruxolitinib—MKNK2—brain—autistic disorder	0.000702	0.00166	CbGeAlD
Ruxolitinib—TAOK3—cerebellum—autistic disorder	0.0007	0.00166	CbGeAlD
Ruxolitinib—RET—brain—autistic disorder	0.000685	0.00162	CbGeAlD
Ruxolitinib—JAK2—brain—autistic disorder	0.000647	0.00153	CbGeAlD
Ruxolitinib—MAP3K3—brain—autistic disorder	0.000624	0.00148	CbGeAlD
Ruxolitinib—TAOK3—brain—autistic disorder	0.000569	0.00135	CbGeAlD
Ruxolitinib—CYP3A4—digestive system—autistic disorder	0.000292	0.000693	CbGeAlD
Ruxolitinib—CYP3A4—nervous system—autistic disorder	0.000226	0.000536	CbGeAlD
Ruxolitinib—CYP3A4—central nervous system—autistic disorder	0.000218	0.000516	CbGeAlD
Ruxolitinib—ROCK1—Signaling Pathways—PIK3CG—autistic disorder	1e-05	1.73e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—APC—autistic disorder	1e-05	1.73e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—TSC2—autistic disorder	9.97e-06	1.72e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—IL6—autistic disorder	9.92e-06	1.72e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—EGF—autistic disorder	9.89e-06	1.71e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—ITGB3—autistic disorder	9.88e-06	1.71e-05	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—IL6—autistic disorder	9.87e-06	1.71e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL2—autistic disorder	9.86e-06	1.71e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—MAPK1—autistic disorder	9.84e-06	1.7e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MEF2C—autistic disorder	9.84e-06	1.7e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—IL6—autistic disorder	9.81e-06	1.7e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PLA2G4A—autistic disorder	9.81e-06	1.7e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—HRAS—autistic disorder	9.76e-06	1.69e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—POMC—autistic disorder	9.68e-06	1.67e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—MTHFR—autistic disorder	9.67e-06	1.67e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—HLA-A—autistic disorder	9.65e-06	1.67e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—PIK3CG—autistic disorder	9.63e-06	1.67e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—PTEN—autistic disorder	9.62e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—ITGB3—autistic disorder	9.59e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—EXT1—autistic disorder	9.57e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC6A8—autistic disorder	9.57e-06	1.66e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—BCL2—autistic disorder	9.56e-06	1.65e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HLA-DRB1—autistic disorder	9.54e-06	1.65e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MEF2C—autistic disorder	9.54e-06	1.65e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—POMC—autistic disorder	9.52e-06	1.65e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IFNG—autistic disorder	9.47e-06	1.64e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—HRAS—autistic disorder	9.37e-06	1.62e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—IL6—autistic disorder	9.34e-06	1.62e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—HRAS—autistic disorder	9.33e-06	1.61e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—SERPINE1—autistic disorder	9.32e-06	1.61e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IGF1—autistic disorder	9.31e-06	1.61e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—ITGB3—autistic disorder	9.3e-06	1.61e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—BCL2—autistic disorder	9.28e-06	1.61e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—PTEN—autistic disorder	9.28e-06	1.6e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—MAPK1—autistic disorder	9.27e-06	1.6e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HTR2A—autistic disorder	9.22e-06	1.59e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—MAPK1—autistic disorder	9.21e-06	1.59e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TSC2—autistic disorder	9.2e-06	1.59e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IFNG—autistic disorder	9.2e-06	1.59e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—PRKCB—autistic disorder	9.2e-06	1.59e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—POMC—autistic disorder	9.17e-06	1.59e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IGF1—autistic disorder	9.16e-06	1.58e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PRL—autistic disorder	9.15e-06	1.58e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—DAO—autistic disorder	9.13e-06	1.58e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—MAPK1—autistic disorder	9.12e-06	1.58e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—MAPK1—autistic disorder	9.04e-06	1.56e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—APOE—autistic disorder	9.01e-06	1.56e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—BCL2—autistic disorder	9e-06	1.56e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL6—autistic disorder	8.96e-06	1.55e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HTR2A—autistic disorder	8.95e-06	1.55e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL2—autistic disorder	8.95e-06	1.55e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IL6—autistic disorder	8.93e-06	1.54e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IFNG—autistic disorder	8.92e-06	1.54e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—HRAS—autistic disorder	8.88e-06	1.54e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—SERPINE1—autistic disorder	8.84e-06	1.53e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TSC2—autistic disorder	8.76e-06	1.52e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—UPB1—autistic disorder	8.76e-06	1.51e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—EGF—autistic disorder	8.7e-06	1.51e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—SERPINE1—autistic disorder	8.7e-06	1.5e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HTR2A—autistic disorder	8.68e-06	1.5e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ADRB2—autistic disorder	8.68e-06	1.5e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—HRAS—autistic disorder	8.65e-06	1.5e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—HRAS—autistic disorder	8.65e-06	1.5e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—HRAS—autistic disorder	8.62e-06	1.49e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—HRAS—autistic disorder	8.58e-06	1.48e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—LEP—autistic disorder	8.57e-06	1.48e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—APOE—autistic disorder	8.57e-06	1.48e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TSC2—autistic disorder	8.5e-06	1.47e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—IL6—autistic disorder	8.5e-06	1.47e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—MAPK1—autistic disorder	8.47e-06	1.47e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL2—autistic disorder	8.42e-06	1.46e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS2—autistic disorder	8.39e-06	1.45e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—HRAS—autistic disorder	8.38e-06	1.45e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—HRAS—autistic disorder	8.36e-06	1.45e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—LEP—autistic disorder	8.32e-06	1.44e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—APOE—autistic disorder	8.32e-06	1.44e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL2—autistic disorder	8.32e-06	1.44e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—IL6—autistic disorder	8.28e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—IL6—autistic disorder	8.28e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—IL6—autistic disorder	8.25e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TSC2—autistic disorder	8.25e-06	1.43e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL6—autistic disorder	8.21e-06	1.42e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL2—autistic disorder	8.17e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AVP—autistic disorder	8.15e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PTGS2—autistic disorder	8.14e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GSTM5—autistic disorder	8.14e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ASMT—autistic disorder	8.14e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—MAPK1—autistic disorder	8.14e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—APC—autistic disorder	8.13e-06	1.41e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IGF2—autistic disorder	8.12e-06	1.4e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PRKCB—autistic disorder	8.08e-06	1.4e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—LEP—autistic disorder	8.07e-06	1.4e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—APOE—autistic disorder	8.07e-06	1.4e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—EGF—autistic disorder	8.03e-06	1.39e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—HRAS—autistic disorder	8.03e-06	1.39e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL6—autistic disorder	8.02e-06	1.39e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—IL6—autistic disorder	8e-06	1.38e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL2—autistic disorder	7.93e-06	1.37e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—PTEN—autistic disorder	7.92e-06	1.37e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—HRAS—autistic disorder	7.9e-06	1.37e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PRKCB—autistic disorder	7.85e-06	1.36e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—PTEN—autistic disorder	7.83e-06	1.35e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—MAPK1—autistic disorder	7.82e-06	1.35e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—APC—autistic disorder	7.74e-06	1.34e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PIK3CG—autistic disorder	7.74e-06	1.34e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—PTEN—autistic disorder	7.69e-06	1.33e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PLA2G4A—autistic disorder	7.66e-06	1.33e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC25A12—autistic disorder	7.65e-06	1.32e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—EGF—autistic disorder	7.65e-06	1.32e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PRKCB—autistic disorder	7.61e-06	1.32e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL6—autistic disorder	7.56e-06	1.31e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MAPK1—autistic disorder	7.54e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PIK3CG—autistic disorder	7.51e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—APC—autistic disorder	7.51e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—IL2—autistic disorder	7.47e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—PTEN—autistic disorder	7.46e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MEF2C—autistic disorder	7.46e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC19A1—autistic disorder	7.44e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—HRAS—autistic disorder	7.44e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—EGF—autistic disorder	7.42e-06	1.28e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—HRAS—autistic disorder	7.4e-06	1.28e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—POMC—autistic disorder	7.36e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—HRAS—autistic disorder	7.32e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PIK3CG—autistic disorder	7.28e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—APC—autistic disorder	7.28e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ITGB3—autistic disorder	7.27e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—HRAS—autistic disorder	7.25e-06	1.25e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—EGF—autistic disorder	7.2e-06	1.25e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL2—autistic disorder	7.16e-06	1.24e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—POMC—autistic disorder	7.15e-06	1.24e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—IL6—autistic disorder	7.12e-06	1.23e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PTEN—autistic disorder	7.1e-06	1.23e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IGF1—autistic disorder	7.08e-06	1.23e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—IL6—autistic disorder	7.08e-06	1.22e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—SERPINE1—autistic disorder	7.07e-06	1.22e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL2—autistic disorder	7.04e-06	1.22e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—BCL2—autistic disorder	7.04e-06	1.22e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—IL6—autistic disorder	7.01e-06	1.21e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IFNG—autistic disorder	6.97e-06	1.21e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—POMC—autistic disorder	6.93e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IGF1—autistic disorder	6.88e-06	1.19e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—MAPK1—autistic disorder	6.84e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—HRAS—autistic disorder	6.8e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HTR2A—autistic disorder	6.78e-06	1.17e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL2—autistic disorder	6.78e-06	1.17e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—PTEN—autistic disorder	6.74e-06	1.17e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—SERPINE1—autistic disorder	6.73e-06	1.16e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IGF1—autistic disorder	6.67e-06	1.15e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ADSL—autistic disorder	6.64e-06	1.15e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—PTEN—autistic disorder	6.62e-06	1.15e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—HRAS—autistic disorder	6.53e-06	1.13e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—SERPINE1—autistic disorder	6.53e-06	1.13e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL6—autistic disorder	6.51e-06	1.13e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—XDH—autistic disorder	6.51e-06	1.13e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TSC2—autistic disorder	6.44e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—MAPK1—autistic disorder	6.44e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—STX1A—autistic disorder	6.39e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NPAS2—autistic disorder	6.39e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MAPK1—autistic disorder	6.37e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—SERPINE1—autistic disorder	6.33e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—APOE—autistic disorder	6.31e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—LEP—autistic disorder	6.31e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—HRAS—autistic disorder	6.28e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—MAPK1—autistic disorder	6.25e-06	1.08e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—IL6—autistic disorder	6.25e-06	1.08e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL2—autistic disorder	6.19e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PTGS2—autistic disorder	6.17e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TCN2—autistic disorder	6.17e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—MAPK1—autistic disorder	6.06e-06	1.05e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—HRAS—autistic disorder	6.05e-06	1.05e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—IL6—autistic disorder	6.01e-06	1.04e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PRKCB—autistic disorder	5.95e-06	1.03e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ADA—autistic disorder	5.89e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—PTEN—autistic disorder	5.83e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL6—autistic disorder	5.8e-06	1e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—MAPK1—autistic disorder	5.77e-06	9.99e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—APC—autistic disorder	5.69e-06	9.84e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PIK3CG—autistic disorder	5.69e-06	9.84e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—EGF—autistic disorder	5.63e-06	9.73e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—HRAS—autistic disorder	5.49e-06	9.5e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MAPK1—autistic disorder	5.48e-06	9.47e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL2—autistic disorder	5.44e-06	9.42e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—POMC—autistic disorder	5.42e-06	9.37e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MAPK1—autistic disorder	5.39e-06	9.32e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PTEN—autistic disorder	5.38e-06	9.31e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—RORA—autistic disorder	5.37e-06	9.28e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL2—autistic disorder	5.28e-06	9.14e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL6—autistic disorder	5.26e-06	9.1e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IGF1—autistic disorder	5.21e-06	9.01e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—MAPK1—autistic disorder	5.19e-06	8.97e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—HRAS—autistic disorder	5.17e-06	8.94e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL2—autistic disorder	5.13e-06	8.87e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PTEN—autistic disorder	5.12e-06	8.86e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—HRAS—autistic disorder	5.11e-06	8.84e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MAOB—autistic disorder	5.03e-06	8.7e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—HRAS—autistic disorder	5.02e-06	8.68e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PTEN—autistic disorder	4.97e-06	8.6e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL6—autistic disorder	4.95e-06	8.56e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SERPINE1—autistic disorder	4.95e-06	8.56e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL6—autistic disorder	4.89e-06	8.46e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—HRAS—autistic disorder	4.87e-06	8.42e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PTEN—autistic disorder	4.82e-06	8.34e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL6—autistic disorder	4.8e-06	8.31e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—MAPK1—autistic disorder	4.74e-06	8.2e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TPH2—autistic disorder	4.68e-06	8.09e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL6—autistic disorder	4.66e-06	8.06e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—HRAS—autistic disorder	4.63e-06	8.02e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—DPYD—autistic disorder	4.6e-06	7.96e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—IL6—autistic disorder	4.44e-06	7.67e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—HRAS—autistic disorder	4.4e-06	7.6e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—MAPK1—autistic disorder	4.37e-06	7.57e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—HRAS—autistic disorder	4.32e-06	7.48e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CACNA1C—autistic disorder	4.28e-06	7.4e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL6—autistic disorder	4.21e-06	7.28e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MAPK1—autistic disorder	4.16e-06	7.2e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—HRAS—autistic disorder	4.16e-06	7.2e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL6—autistic disorder	4.14e-06	7.16e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MAPK1—autistic disorder	4.04e-06	6.99e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL2—autistic disorder	4e-06	6.93e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL6—autistic disorder	3.98e-06	6.89e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MAPK1—autistic disorder	3.92e-06	6.78e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—DHFR—autistic disorder	3.89e-06	6.73e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HRAS—autistic disorder	3.8e-06	6.58e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PTEN—autistic disorder	3.77e-06	6.52e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL6—autistic disorder	3.64e-06	6.3e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—HRAS—autistic disorder	3.51e-06	6.08e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—IL6—autistic disorder	3.36e-06	5.81e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—HRAS—autistic disorder	3.34e-06	5.78e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—HRAS—autistic disorder	3.25e-06	5.61e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL6—autistic disorder	3.2e-06	5.53e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—HRAS—autistic disorder	3.15e-06	5.44e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL6—autistic disorder	3.11e-06	5.37e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MAPK1—autistic disorder	3.06e-06	5.3e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP19A1—autistic disorder	3.05e-06	5.27e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL6—autistic disorder	3.01e-06	5.21e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—COMT—autistic disorder	2.83e-06	4.9e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GSTP1—autistic disorder	2.82e-06	4.88e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MAOA—autistic disorder	2.81e-06	4.87e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CAT—autistic disorder	2.74e-06	4.75e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PLA2G4A—autistic disorder	2.59e-06	4.48e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GSTM1—autistic disorder	2.59e-06	4.48e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GPX1—autistic disorder	2.48e-06	4.29e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—HRAS—autistic disorder	2.46e-06	4.25e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL6—autistic disorder	2.35e-06	4.07e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MTHFR—autistic disorder	2.29e-06	3.96e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—APOE—autistic disorder	2.13e-06	3.69e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PIK3CG—autistic disorder	1.92e-06	3.33e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—POMC—autistic disorder	1.83e-06	3.17e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGS2—autistic disorder	1.46e-06	2.53e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTEN—autistic disorder	1.27e-06	2.2e-06	CbGpPWpGaD
